Considerations on the Off-label Use of Ketamine as a Treatment for Mood Disorders
Samuel T. Wilkinson, Gerard Sanacora
JAMA August 14, 2017 DOI: 10.1001/jama.2017.10697 via OpenAlex
Summary
AI-generated from the abstractKetamine shows promise for treating psychiatric disorders, but important issues remain regarding its clinical use. A consensus statement addresses these concerns and offers suggestions for managing them, highlighting the need for careful consideration of ketamine's risks and benefits in psychiatric practice.
Study at a glance
| Characteristics | Viewpoint Peer reviewed |
|---|---|
| Topics | Anxiety Ketamine |
| Keywords | Mood disorders Statement logic Psychiatry Intensive care medicine |
| Citations | 36 |
| Key finding | A consensus statement addresses important issues related to the clinical use of ketamine for psychiatric disorders and provides suggestions for addressing remaining concerns. |
Abstract
This Viewpoint summarizes a number of important issues related to the clinical use of ketamine for the treatment of psychiatric disorders addressed in the consensus statement and provides suggestions for addressing remaining concerns.